The insurer relied on an arbitrary policy to consistently deny coverage for the therapy on the grounds that it was experimental or investigational, the April 3 lawsuit claims. But proton beam radiation therapy has been recognized “for decades” by the medical community as an established, appropriate cancer treatment, according to the lawsuit.
The lawsuit, which seeks to represent a class of patients with prostate cancer, comes one week after the insurer was hit with a similar class ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
